Pharmaceutical multinational AstraZeneca has enlisted London -based healthtech start-up Umotif to create digital tools to capture data about people's use of its drugs and to monitor clinical trials. AstraZeneca described the deal as "financially significant". Umotif, which created the first -ever app to be prescribed by the NHS , allows people to submit anonymous information about their illness via their smartphone, with the data analysed by medical professionals. In the last 12 months Umotif , around 18,000 people suffering from around 18,000 types of condition have provided around 18,000 data points.
Pharmaceutical multinational AstraZeneca has enlisted London-based healthtech start-up Umotif to create digital tools to capture data about people's use of its drugs and to monitor clinical trials. AstraZeneca described the deal as "financially significant". Umotif, which created the first-ever app to be prescribed by the NHS, allows people to submit anonymous information about their illness via their smartphone, with the data analysed by medical professionals. In the past year, around 18,000 people suffering from 16 types of condition have provided 64 million data points.